Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$5.01M
13 trades
Open-market sells
$22M
39 trades
Net flow
−$16.98M
Net selling
Total filings
59
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
Advertisement
ZLCS
Sell MPM BIOVENTURES III LLC · 10% Owner · Open-market sale · filed Oct 28, 2011 ΔOwn −6.2%

Mpm Bioventures Iii Llc sold $761K of ZLCS, trimming their stake 6%.

−$761K
738,807 sh @ $1
ZLCS
Sell MPM BIOVENTURES III LLC · 10% Owner · Open-market sale · filed Oct 27, 2011 ΔOwn −0.7%

Mpm Bioventures Iii Llc sold $79.6K of ZLCS, trimming their stake 1%.

−$79.6K
78,000 sh @ $1
ZLCS
Sell MPM BIOVENTURES III LLC · 10% Owner · Open-market sale · filed Oct 27, 2011 ΔOwn −1.7%

Mpm Bioventures Iii Llc sold $207.3K of ZLCS, trimming their stake 2%.

−$207.3K
203,200 sh @ $1
ZLCS
Sell MPM BIOVENTURES III LLC · 10% Owner · Open-market sale · filed Oct 25, 2011 ΔOwn −2.0%

Mpm Bioventures Iii Llc sold $259.6K of ZLCS, trimming their stake 2%.

−$259.6K
252,000 sh @ $1
ZLCS
Sell MPM BIOVENTURES III LLC · 10% Owner · Open-market sale · filed Oct 25, 2011 ΔOwn −0.6%

Mpm Bioventures Iii Llc sold $71.5K of ZLCS, trimming their stake 1%.

−$71.5K
70,100 sh @ $1
ZLCS
Sell MPM BIOVENTURES III LLC · 10% Owner · Open-market sale · filed Oct 21, 2011 ΔOwn −3.3%

Mpm Bioventures Iii Llc sold $437.8K of ZLCS, trimming their stake 3%.

−$437.8K
425,000 sh @ $1
ZLCS
Sell MPM BIOVENTURES III LLC · 10% Owner · Open-market sale · filed Oct 21, 2011 ΔOwn −0.3%

Mpm Bioventures Iii Llc sold $35.5K of ZLCS.

−$35.5K
34,817 sh @ $1
ZLCS
Sell MPM BIOVENTURES III LLC · 10% Owner · Open-market sale · filed Oct 19, 2011 ΔOwn −0.2%

Mpm Bioventures Iii Llc sold $20K of ZLCS.

−$20K
19,644 sh @ $1
ZLCS
Sell MPM BIOVENTURES III LLC · 10% Owner · Open-market sale · filed Oct 17, 2011 ΔOwn −0.3%

Mpm Bioventures Iii Llc sold $40.5K of ZLCS.

−$40.5K
39,700 sh @ $1
ZLCS
Sell MPM BIOVENTURES III LLC · 10% Owner · Open-market sale · filed Oct 13, 2011 ΔOwn −1.0%

Mpm Bioventures Iii Llc sold $13.44M of ZLCS, trimming their stake 1%.

−$13.44M
131,800 sh @ $102
ZLCS
Sell MPM BIOVENTURES III LLC · 10% Owner · Open-market sale · filed Oct 13, 2011 ΔOwn −1.5%

Mpm Bioventures Iii Llc sold $210.6K of ZLCS, trimming their stake 2%.

−$210.6K
206,500 sh @ $1

Frequently asked questions

How is MPM BIOVENTURES III LLC's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from MPM BIOVENTURES III LLC's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.